Dyne Therapeutics Inc (DYN) is down -1.93% in a Week, Should You Sell?

A rating of 86 puts Dyne Therapeutics Inc (DYN) near the top of the Biotechnology industry according to InvestorsObserver. Dyne Therapeutics Inc's score of 86 means it scores higher than 86% of stocks in the industry. Dyne Therapeutics Inc also received an overall rating of 71, putting it above 71% of all stocks. Biotechnology is ranked 22 out of the 148 industries.

DYN has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on DYN!

See Full DYN Report

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 71 would rank higher than 71 percent of all stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Dyne Therapeutics Inc Stock Today?

Dyne Therapeutics Inc (DYN) stock has risen 10.48% while the S&P 500 is down -0.92% as of 2:11 PM on Monday, Sep 26. DYN has gained $1.30 from the previous closing price of $12.41 on volume of 294,962 shares. Over the past year the S&P 500 has fallen -17.65% while DYN is down -16.25%. DYN lost -$3.54 per share the over the last 12 months. Click Here to get the full Stock Report for Dyne Therapeutics Inc stock.